Merck Announces Third-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Tech selloff weighs down Wall Street as bond yields climb
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Merck (MRK) PT Raised to $90 at Morgan Stanley on Gardasil Strength
October 29, 2021 8:46 AM EDTMorgan Stanley analyst Matthew Harrison raised the price target on Merck (NYSE: MRK) to $90.00 (from $88.00) while maintaining a Equalweight rating after 3Q total revenue beat expectations driven primarily by Gardasil sales due to strong global demand and increased supply. Management expects robust... More
Merck (MRK) Stock Gains on Beat-and-Raise, Sees Up To $7 Billion in Sales of COVID-19 Drug, Analysts Bullish
October 28, 2021 9:21 AM EDTShares of Merck (NYSE: MRK) are up 1.5% in pre-open Thursday after the biotech company delivered better-than-expected Q3 results.
Merck said it earned $1.75 per share to top the analyst estimate of $1.55. Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $12.33 billion.
Merck delivered another strong quarter with positive momentum across our business and meaningful progress across our pipeline. Our teams continued to excel as we focus on... More
Merck (MRK) Tops Q3 EPS by 20c, Offers FY Guidance
October 28, 2021 6:35 AM EDTMerck (NYSE: MRK) reported Q3 EPS of $1.75, $0.20 better than the analyst estimate of $1.55. Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $12.33 billion.
GUIDANCE:
Merck sees FY2021 EPS of $5.65-$5.70, versus the consensus of $5.77. Merck sees... More
